Codrituzumab (GC3) is a humanized antibody against the glypican-3 hepatocellular carcinoma protein that can be used in combination with sorafenib to study incurable advanced hepatocellular carcinoma (HCC).
Purity:
>95%
CAS Number:
[1365267-33-9]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted